Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 661 results found. Search for [ Lupin ]

Results 1 to 21 of 661
Niti Kiran
November 14, 2019
An improvement in exports to the US, the key market for Indian drug manufacturers, drove the growth in overall exports from India


BusinessToday.In
November 13, 2019
Lupin Pharma has sold the entire stake (99.82%) in its Japanese subsidiary Kyowa to Unison's entity Plutus Ltd, Japan, for an enterprise value of $300 million, subject to closing adjustments


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
New Delhi, November 12, 2019
The deal proceeds will be utilised to strengthen Lupin's balance sheet as well as provide growth capital to support organic and inorganic initiatives for our focus markets, says Lupin CEO Vinita Gupta


BusinessToday.In
New Delhi, November 12, 2019
Benchmark indices Sensex and Nifty ended marginally higher (0.04 per cent) on Monday on weak global equities amid diminishing US-China trade deal hopes


BusinessToday.In
November 11, 2019
Amara Raja's stock opened with a gain of 3.36% today and later jumped 11.58% to touch the intraday high of Rs 729.75 on the BSE


BusinessToday.In
November 11, 2019
The 'Advertising & Media' sector firm also reported a healthy  evenue from operations that surged 40.4% to Rs 84.7 crore as against Rs 60.3 crore in the same quarter last year


PTI
November 11, 2019
At the interbank foreign exchange, the rupee opened at 71.36 against the US dollar, showing a decline of 8 paise over its previous closing


PB Jayakumar
New Delhi, November 8, 2019
Sun Pharma Q2 results: The drugmaker, which earns 37 per cent of its business from the US market, earned Rs 2,389.77 crore from the sale of formulations in the US in Q2FY20 against Rs 2397 crore in the corresponding quarter of the previous year


PTI
November 8, 2019
Revenue from operations stood at Rs 4,007.63 crore as against Rs 3,946.77 crore in the same period a year ago, a growth of 1.57 per cent


BusinessToday.In
November 8, 2019
The share purchase by Jhunjhunwala comes at a time when YES Bank finds itself on a sticky wicket in terms of its financial position


BusinessToday.In
New Delhi, November 7, 2019
HPCL Q2 results: Total income in July-September dipped 9.40 per cent to Rs 66,850.89 crore against Rs 73,789.50 crore in Q2FY19


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


BusinessToday.In
New Delhi, November 6, 2019
Lupin Q2 results: Consolidated revenue from operations of the pharma major increased 10.3 per cent year-on-year (YoY) to Rs 4,359.7 crore in Q2FY20 as against Rs 3,951 crore in Q2FY19


PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


Manu Kaushik
New Delhi, October 30, 2019
Even though Gangwal stands on thin ice if the powers entrusted in the shareholders' agreement are considered; Bhatia has much more to lose if this matter escalates further


PTI
October 7, 2019



BusinessToday.In
New Delhi, October 7, 2019
Weighed down by USFDA observations, share price of Aurobindo Pharma declined as much as 20.65 per cent to hit a 52-week low of Rs 450 on the BSE, after opening tad lower at Rs 560 against previous close level of Rs 567.15 on the BSE


PTI
October 7, 2019



PTI
October 3, 2019
\"Sreeji brings to Lupin over 20 years of significant domain expertise and global experience,\" Lupin said in a statement


PAGES 1 OF 34  12345